Cochrane Abstracts
Gene therapy for sickle cell disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Gene Therapy for Sickle Cell Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434604/all/Gene_therapy_for_sickle_cell_disease.
Gene therapy for sickle cell disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434604/all/Gene_therapy_for_sickle_cell_disease. Accessed January 9, 2025.
Gene therapy for sickle cell disease. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434604/all/Gene_therapy_for_sickle_cell_disease
Gene Therapy for Sickle Cell Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2025 January 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434604/all/Gene_therapy_for_sickle_cell_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Gene therapy for sickle cell disease
ID - 434604
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434604/all/Gene_therapy_for_sickle_cell_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
